To further test this, we generated in vivo xenograft tumors of the parental and USP22-Ko A549 cancer cells in mouse, and then the xenografts were treated with a USP7-specific inhibitor P5091 at the previously reported concentration [16]. This evidence concerns the gene USP22 and cancer.